FLUTINASE Polynex susp 28 monodos 0.4 ml

7680548850164 CH-54885 R01AD08 12.02.3.
FLUTINASE Polynex susp 28 monodos 0.4 ml
FLUTINASE Polynex susp 28 monodos 0.4 ml
FLUTINASE Polynex susp 28 monodos 0.4 ml
1 / 3
google

Details

Product number
5488501
CPT
-
Packaging group
28
Unit
Einzeldose(n)
Composition
fluticasoni propionas 400 µg, polysorbatum 20, sorbitani lauras, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, natrii chloridum, aqua ad iniectabile, ad suspensionem pro 0.4 ml.

Articles (1)

Flutinase Polynex, Nasentropfen, Suspension in Einzeldosen
Nasentropfen
28
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
fluticasoni propionas
400.0 UG Substance Wirkstoff (Principe actif)
polysorbatum 20
- Substance HNIDK
sorbitani lauras
- Substance HNIDK
natrii dihydrogenophosphas dihydricus
- Substance HNIDK
dinatrii phosphas
- Substance HNIDK
natrii chloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
54885
Drug name
Flutinase Polynex, Nasentropfen, Suspension in Einzeldosen
Galenic form
NASNS
ATC Code
R01AD08
Authorization status
Revoked/Withdrawn
Dispensation category
B
First authorization
25/06/1999
Authorization expiration date
04/11/2025
IT number
12.02.3.
Domain
Human medicine
Field of application
Kortikoid-Rhinologikum zur Behandlung von Nasenpolypen

Packaging details

Description (FR)
FLUTINASE Polynex susp 28 monodos 0.4 ml
Description (DE)
FLUTINASE Polynex Susp 28 Monodos 0.4 ml
Market launch
25/06/1999
Market withdrawal
19/09/2023
Narcotic (BTM)
No

Available generics

Nasofan, Nasenspray, Suspension
CHF 25.60
View
Buy us a coffee Explore the data